Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
Seeking Young Scientists for Research in Space
Sounds of Science Podcasts
Tackling the Inevitability of Resistance One Genome at a Time
Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Status of Cancer Clinical Trials
The Institute of Medicine of the National Academies reports that the state of cancer clinical trials in the U.S. has reached crisis mode. The study cites a number of factors responsible for this situation, such as too much bureaucracy, wasted funds, and lack of patient enrollment. Do you think that the Institute’s proposed goals of (1) improving the speed and efficiency of the design, launch, and conduct of clinical trials, (2) making optimal use of scientific innovations, (3) achieving better selection, prioritization, support, and completion of clinical trials, and (4) fostering expanded participation of both patients and physicians will effectively address the crisis in cancer clinical trials?